Skip to content

Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Prospective Randomized Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02171364
Enrollment
40
Registered
2014-06-24
Start date
2014-08-31
Completion date
2015-09-01
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Atrial fibrillation, Virtual ablation, electrocardiography, electroanatomical mapping data

Brief summary

Radiofrequency catheter ablation is highly effective in the treatment of patients with persistent atrial fibrillation. In order to decrease the recurrence rate after catheter ablation, the investigators propose to apply 'virtual' ablation on patient-specific atria by simulating 3D atrial computer model. The investigators will test with five different set of ablation methods and find successful methods for a specific patient. Then, this result will be compared to empirical catheter ablation result by randomly controlled trial.

Interventions

PROCEDUREVirtual ablation in based 3D CT of patient who diagnosed AF
PROCEDUREconventional ablation based on physician's personal experience

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of AF patients who performed catheter ablation of atrial fibrillation due to uncontrolled pulse rate by anti-arrhythmic drug therapy.

Exclusion criteria

* AF patients who have severe heart deformations or blood problems. * The patients who had been performed catheter ablation of atrial ablation. * The patients who missed out to recording of 3D CT, echo and electrocardiography.

Design outcomes

Primary

MeasureTime frame
change of hospitalization rate1, 3, 6, 12, 18 and 24 months after catheter ablation and every 6 months thereafter.

Secondary

MeasureTime frame
occurence of cardiovascular disease6 months
recurrence of AF6 months

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026